Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurence Collette

Showing results (41-50 of 155) with videos related to

Pageof 16
Sort By:
The Journal of Urology|November 22, 2017
Impact of Primary Tumor Location on Survival from the European Organization for the Research and Treatment of Cancer Advanced Urothelial Cancer StudiesMarco Moschini, Shahrokh F Shariat, Morgan Rouprêt, et al.
European Urology|October 1, 2008
Early versus delayed endocrine treatment of T2-T3 pN1-3 M0 prostate cancer without local treatment of the primary tumour: final results of European Organisation for the Research and Treatment of Cancer protocol 30846 after 13 years of follow-up (a randomised controlled trial)Fritz H Schröder, Karl-Heinz Kurth, Sophie D Fossa, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 28, 2013
Quality assurance of the EORTC 22043-30041 trial in post-operative radiotherapy in prostate cancer: results of the Dummy Run procedurePaul A Fenton, Coen Hurkmans, Akos Gulyban, et al.
The Journal of Urology|August 18, 2004
Early versus delayed endocrine treatment of pN1-3 M0 prostate cancer without local treatment of the primary tumor: results of European Organisation for the Research and Treatment of Cancer 30846--a phase III studyFritz H Schröder, Karl Heinz Kurth, Sophie D Fosså, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2004
Is baseline quality of life useful for predicting survival with hormone-refractory prostate cancer? A pooled analysis of three studies of the European Organisation for Research and Treatment of Cancer Genitourinary GroupLaurence Collette, George van Andel, Andrew Bottomley, et al.
European Journal of Cancer (Oxford, England : 1990)|January 19, 2019
A multinational, multi-tumour basket study in very rare cancer types: The European Organization for Research and Treatment of Cancer phase II 90101 'CREATE' trialJulien Péron, Sandrine Marreaud, Dominiek Staelens, et al.
European Radiology|December 18, 2019
MRI versus <sup>18</sup>F-FDG-PET/CT for detecting bone marrow involvement in multiple myeloma: diagnostic performance and clinical relevanceFrédéric E Lecouvet, Dimitar Boyadzhiev, Laurence Collette, et al.
Annals of Surgery|November 10, 2016
From a Comic Opera to Surcare an Open Letter to Whom Clinical Research in Surgery Is a Concern: Announcing the Launch of SURCARESerge Evrard, Ricardo Audisio, Graeme Poston, et al.
Cancers|November 13, 2021
Comparison of <sup>68</sup>Ga-Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography Computed Tomography (PET-CT) and Whole-Body Magnetic Resonance Imaging (WB-MRI) with Diffusion Sequences (DWI) in the Staging of Advanced Prostate CancerJulien Van Damme, Bertrand Tombal, Laurence Collette, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2007
Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology GroupLaurence Collette, Jean-Francois Bosset, Marcel den Dulk, et al.
Pageof 16

Showing results (41-50 of 155) with videos related to

Sort By:
Pageof 16
The Journal of Urology|November 22, 2017
Impact of Primary Tumor Location on Survival from the European Organization for the Research and Treatment of Cancer Advanced Urothelial Cancer StudiesMarco Moschini, Shahrokh F Shariat, Morgan Rouprêt, et al.
European Urology|October 1, 2008
Early versus delayed endocrine treatment of T2-T3 pN1-3 M0 prostate cancer without local treatment of the primary tumour: final results of European Organisation for the Research and Treatment of Cancer protocol 30846 after 13 years of follow-up (a randomised controlled trial)Fritz H Schröder, Karl-Heinz Kurth, Sophie D Fossa, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 28, 2013
Quality assurance of the EORTC 22043-30041 trial in post-operative radiotherapy in prostate cancer: results of the Dummy Run procedurePaul A Fenton, Coen Hurkmans, Akos Gulyban, et al.
The Journal of Urology|August 18, 2004
Early versus delayed endocrine treatment of pN1-3 M0 prostate cancer without local treatment of the primary tumor: results of European Organisation for the Research and Treatment of Cancer 30846--a phase III studyFritz H Schröder, Karl Heinz Kurth, Sophie D Fosså, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2004
Is baseline quality of life useful for predicting survival with hormone-refractory prostate cancer? A pooled analysis of three studies of the European Organisation for Research and Treatment of Cancer Genitourinary GroupLaurence Collette, George van Andel, Andrew Bottomley, et al.
European Journal of Cancer (Oxford, England : 1990)|January 19, 2019
A multinational, multi-tumour basket study in very rare cancer types: The European Organization for Research and Treatment of Cancer phase II 90101 'CREATE' trialJulien Péron, Sandrine Marreaud, Dominiek Staelens, et al.
European Radiology|December 18, 2019
MRI versus <sup>18</sup>F-FDG-PET/CT for detecting bone marrow involvement in multiple myeloma: diagnostic performance and clinical relevanceFrédéric E Lecouvet, Dimitar Boyadzhiev, Laurence Collette, et al.
Annals of Surgery|November 10, 2016
From a Comic Opera to Surcare an Open Letter to Whom Clinical Research in Surgery Is a Concern: Announcing the Launch of SURCARESerge Evrard, Ricardo Audisio, Graeme Poston, et al.
Cancers|November 13, 2021
Comparison of <sup>68</sup>Ga-Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography Computed Tomography (PET-CT) and Whole-Body Magnetic Resonance Imaging (WB-MRI) with Diffusion Sequences (DWI) in the Staging of Advanced Prostate CancerJulien Van Damme, Bertrand Tombal, Laurence Collette, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2007
Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology GroupLaurence Collette, Jean-Francois Bosset, Marcel den Dulk, et al.
Pageof 16